Iron deficiency (ID) and iron deficiency anemia (IDA) are highly prevalent among women across their life span, especially during the reproductive age. An iron-deficient state has been associated with a number of adverse health consequences, affecting all aspects of the physical and emotional well-being of women. Heavy menstrual bleeding, pregnancy state, and the postpartum period are the major causes of ID/IDA. However, despite the high prevalence and the impact on quality of life, ID/IDA among fertile age women remains underdiagnosed and undertreated.The present Views and Reviews provides an overview on IDA in women's health, describing the background on iron metabolism, heavy menstrual bleeding pathogenetic mechanisms, including a focus on uterine disorders, such as uterine fibroids and adenomyosis. Iron replacement therapies, patient blood management, and treatment options for uterine disorders also are explored. (Fertil Sterile 2022;118:605-6.(c) 2022 by American Society for Reproductive Medicine.)
Iron deficiency anemia: Impact on women's reproductive health / Petraglia, Felice; Dolmans, Marie Madeleine. - In: FERTILITY AND STERILITY. - ISSN 0015-0282. - ELETTRONICO. - 118:(2022), pp. 0-0. [10.1016/j.fertnstert.2022.08.850]
Iron deficiency anemia: Impact on women's reproductive health
Petraglia, Felice;
2022
Abstract
Iron deficiency (ID) and iron deficiency anemia (IDA) are highly prevalent among women across their life span, especially during the reproductive age. An iron-deficient state has been associated with a number of adverse health consequences, affecting all aspects of the physical and emotional well-being of women. Heavy menstrual bleeding, pregnancy state, and the postpartum period are the major causes of ID/IDA. However, despite the high prevalence and the impact on quality of life, ID/IDA among fertile age women remains underdiagnosed and undertreated.The present Views and Reviews provides an overview on IDA in women's health, describing the background on iron metabolism, heavy menstrual bleeding pathogenetic mechanisms, including a focus on uterine disorders, such as uterine fibroids and adenomyosis. Iron replacement therapies, patient blood management, and treatment options for uterine disorders also are explored. (Fertil Sterile 2022;118:605-6.(c) 2022 by American Society for Reproductive Medicine.)File | Dimensione | Formato | |
---|---|---|---|
1-s2.0-S0015028222013723-main.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
130.3 kB
Formato
Adobe PDF
|
130.3 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.